Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 646 1.40%
01 Jun - close price
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 9,659 Cr.
  • Current Price ₹ 646
  • High / Low ₹ 800 / 512
  • Stock P/E 147
  • Book Value ₹ 107
  • Dividend Yield 0.00 %
  • ROCE 6.14 %
  • ROE 4.72 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 6.01 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Tax rate seems low
  • Company has a low return on equity of 2.90% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.16%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
258.67 272.23 282.75 285.81 299.93 293.61 329.25 312.51 324.38 327.09 345.84 342.16 350.21
218.69 224.69 232.34 237.06 243.32 243.72 267.67 270.19 265.49 277.24 283.54 287.86 275.07
Operating Profit 39.98 47.54 50.41 48.75 56.61 49.89 61.58 42.32 58.89 49.85 62.30 54.30 75.14
OPM % 15.46% 17.46% 17.83% 17.06% 18.87% 16.99% 18.70% 13.54% 18.15% 15.24% 18.01% 15.87% 21.46%
0.56 1.83 2.13 5.04 -12.43 10.50 9.79 -29.53 9.46 7.94 3.82 -4.87 -32.60
Interest 9.57 9.69 10.98 13.70 14.61 19.34 20.58 21.27 22.50 24.30 21.36 20.61 20.19
Depreciation 23.06 21.64 23.28 24.80 25.90 25.84 27.88 27.90 29.05 28.25 30.16 30.09 31.30
Profit before tax 7.91 18.04 18.28 15.29 3.67 15.21 22.91 -36.38 16.80 5.24 14.60 -1.27 -8.95
Tax % 47.16% 24.11% 25.05% 43.30% 145.78% 22.95% 21.65% 2.61% 39.58% 34.16% 26.16% -7.09% -117.09%
4.18 13.69 13.70 8.67 -1.68 11.72 17.95 -37.33 10.15 3.45 10.78 -1.18 1.53
EPS in Rs 0.28 0.93 0.93 0.59 -0.11 0.79 1.22 -2.53 0.69 0.23 0.72 -0.08 0.10
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
420 471 545 586 640 688 609 850 1,006 1,171 1,277 1,365
364 407 462 498 546 573 535 703 824 970 1,065 1,124
Operating Profit 56 64 83 88 94 116 74 147 181 201 211 242
OPM % 13% 14% 15% 15% 15% 17% 12% 17% 18% 17% 17% 18%
0 -1 7 19 13 -19 -129 65 7 0 4 -26
Interest 32 34 16 27 48 83 63 43 41 50 84 86
Depreciation 33 37 44 44 47 79 87 88 89 97 111 120
Profit before tax -8 -9 29 37 13 -65 -205 81 58 54 20 10
Tax % -69% -45% 34% 32% 42% -19% -7% 53% 30% 39% 82% -52%
-2 -5 19 25 7 -53 -192 38 40 33 4 15
EPS in Rs -0.32 -0.52 2.15 2.71 0.78 -5.68 -14.43 2.60 2.73 2.22 0.24 0.98
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 18%
3 Years: 11%
TTM: 7%
Compounded Profit Growth
10 Years: 88%
5 Years: 30%
3 Years: 15%
TTM: 3994%
Stock Price CAGR
10 Years: 14%
5 Years: 29%
3 Years: 27%
1 Year: 20%
Return on Equity
10 Years: 2%
5 Years: 3%
3 Years: 3%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 85 86 87 88 89 125 139 139 139 139 149
Reserves 202 435 459 552 557 526 798 959 1,006 1,042 1,052 1,455
311 194 218 264 422 827 481 349 347 758 1,118 1,022
107 136 159 210 337 328 169 197 237 299 295 291
Total Liabilities 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,239 2,604 2,917
405 431 442 492 547 914 745 774 788 974 1,038 1,122
CWIP 28 29 33 79 104 44 28 5 9 36 23 14
Investments 84 155 141 219 299 316 366 439 475 506 696 704
173 235 306 322 454 495 436 426 458 722 847 1,078
Total Assets 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,239 2,604 2,917

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
51 58 54 66 87 86 71 124 130 209 146 160
-74 -86 -73 -185 -208 -116 -246 49 -138 -254 -347 -76
22 120 -14 91 66 -3 236 -41 -42 96 -42 336
Net Cash Flow -1 92 -33 -27 -55 -32 61 132 -49 51 -243 421
Free Cash Flow -17 -32 18 -37 -36 6 48 82 36 80 13 8
CFO/OP 90% 102% 74% 74% 120% 92% 41% 95% 81% 121% 78% 70%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 56 54 67 79 83 81 88 69 77 69 75 70
Inventory Days 36 30 36 40 39 31 32 30 33 30 23 26
Days Payable 208 266 257 269 253 247 214 167 168 192 175 168
Cash Conversion Cycle -116 -182 -154 -150 -131 -135 -94 -68 -59 -93 -77 -71
Working Capital Days -64 -74 -69 -24 -82 -133 38 9 26 -37 -70 -41
ROCE % 5% 5% 6% 7% 6% 4% 1% 5% 7% 7% 7% 6%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Bed Occupancy Rate
%

Log in to view insights

Please log in to see hidden values.

Login
Number of Cancer Centers / Hospitals
Number
Operational Beds
Number
ARPOB / ARPP
INR
Number of LINACs
Number
New Patient Registrations (Oncology)
Number
Number of PET CTs
Number
IVF Cycles (Milann)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
71.35% 71.30% 71.29% 71.28% 71.26% 71.23% 71.22% 71.22% 62.46% 63.78% 63.77% 64.21%
6.47% 6.29% 6.37% 6.74% 3.95% 4.30% 2.77% 2.44% 2.16% 3.59% 3.22% 2.76%
6.58% 7.94% 8.46% 8.52% 10.89% 11.64% 12.94% 12.48% 13.22% 18.36% 18.30% 18.91%
15.59% 14.49% 13.89% 13.45% 13.90% 12.84% 13.07% 13.86% 22.17% 14.28% 14.71% 14.15%
No. of Shareholders 25,93127,32727,28927,19526,52929,67032,82045,39447,02846,97045,36647,649

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls